The agency has ordered compounding pharmacies to stop making compound versions of GLP-1 drugs now that the drugs are no longer in short supply. Eli Lilly, the maker of Zepbound and Mounjaro, and Novo ...

The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...

For the second time, a federal judge has ordered the Trump administration to pay out money Congress appropriated to foreign ...

Mineralys Therapeutics said on Monday its lead drug significantly lowered blood pressure in patients with difficult-to-treat hypertension in late- and mid-stage trials.

Several U.S. refugee resettlement organizations asked a federal judge on Monday to restore the U.S. refugee program, arguing President Donald Trump's indefinite suspension is unlawful and is ...

Compounders had been allowed to produce and sell hundreds of thousands of their own versions of popular anti-obesity drugs, so long as the FDA considered them in shortage.

A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and ...

Spironolactone is a diuretic (water pill) commonly used to treat heart failure and high blood pressure, but it can also be used for other conditions.